[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 241
Citations 0
Health Agencies Update
November 27, 2013

FDA Funds Development of Drugs and Devices for Rare Diseases

JAMA. 2013;310(20):2140. doi:10.1001/jama.2013.283509

The US Food and Drug Administration (FDA) recently awarded $14 million in grants to boost the development of drugs or devices for rare diseases (http://1.usa.gov/1bPq5q8).

The Orphan Drug Act was passed in 1983 to promote the development of treatments for roughly 6800 rare diseases and conditions that currently affect nearly 30 million US individuals. In awarding grants for orphan drug research, the FDA considers treatments for conditions that affect fewer than 200 000 persons. For devices, the Humanitarian Use Device program is geared toward devices for conditions that affect fewer than 4000 in the United States per year.

First Page Preview View Large
First page PDF preview
First page PDF preview